Tiotropium add-on therapy improves lung function in children with symptomatic moderate asthma.

[1]  A. Boner,et al.  A phase III randomized controlled trial of tiotropium add‐on therapy in children with severe symptomatic asthma , 2017, The Journal of allergy and clinical immunology.

[2]  A. Boner,et al.  A randomised controlled trial of tiotropium in adolescents with severe symptomatic asthma , 2017, European Respiratory Journal.

[3]  A. Boner,et al.  Tiotropium add-on therapy in adolescents with moderate asthma: A 1-year randomized controlled trial. , 2016, The Journal of allergy and clinical immunology.

[4]  M. Ní Chróinín,et al.  Addition of long-acting beta2-agonists to inhaled corticosteroids for chronic asthma in children. , 2015, The Cochrane database of systematic reviews.

[5]  E. Bleecker,et al.  Tiotropium or salmeterol as add-on therapy to inhaled corticosteroids for patients with moderate symptomatic asthma: two replicate, double-blind, placebo-controlled, parallel-group, active-comparator, randomised trials. , 2015, The Lancet. Respiratory medicine.

[6]  F. Ducharme,et al.  Addition of anti-leukotriene agents to inhaled corticosteroids in children with persistent asthma. , 2013, The Cochrane database of systematic reviews.

[7]  Michael Engel,et al.  Tiotropium in asthma poorly controlled with standard combination therapy. , 2012, The New England journal of medicine.

[8]  D. Halpin,et al.  The Effect of Tiotropium in Symptomatic Asthma Despite Low- to Medium-Dose Inhaled Corticosteroids: A Randomized Controlled Trial. , 2016, The journal of allergy and clinical immunology. In practice.